SG94684A1 - Wound healing compositions containing fibroblast growth factor and ascorbic acid - Google Patents

Wound healing compositions containing fibroblast growth factor and ascorbic acid

Info

Publication number
SG94684A1
SG94684A1 SG9605433A SG1996005433A SG94684A1 SG 94684 A1 SG94684 A1 SG 94684A1 SG 9605433 A SG9605433 A SG 9605433A SG 1996005433 A SG1996005433 A SG 1996005433A SG 94684 A1 SG94684 A1 SG 94684A1
Authority
SG
Singapore
Prior art keywords
ascorbic acid
growth factor
wound healing
compositions containing
fibroblast growth
Prior art date
Application number
SG9605433A
Other languages
English (en)
Inventor
Jeffrey C Geesin
Joel S Gordon
Original Assignee
Johnson & Johnson Consumer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson Consumer filed Critical Johnson & Johnson Consumer
Publication of SG94684A1 publication Critical patent/SG94684A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
SG9605433A 1991-01-02 1991-12-31 Wound healing compositions containing fibroblast growth factor and ascorbic acid SG94684A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63684391A 1991-01-02 1991-01-02

Publications (1)

Publication Number Publication Date
SG94684A1 true SG94684A1 (en) 2003-03-18

Family

ID=24553567

Family Applications (1)

Application Number Title Priority Date Filing Date
SG9605433A SG94684A1 (en) 1991-01-02 1991-12-31 Wound healing compositions containing fibroblast growth factor and ascorbic acid

Country Status (9)

Country Link
EP (1) EP0493985B1 (es)
JP (1) JPH0570365A (es)
AT (1) ATE181082T1 (es)
AU (1) AU9008691A (es)
CA (1) CA2058597C (es)
DE (1) DE69131318T2 (es)
ES (1) ES2132082T3 (es)
GR (1) GR1002610B (es)
SG (1) SG94684A1 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002513383A (ja) 1997-05-21 2002-05-08 スローン−ケタリング・インスティテュート・フォー・キャンサー・リサーチ 患者の脳組織でのアスコルビン酸の濃度を増加させる方法
US6262111B1 (en) 1997-05-21 2001-07-17 Sloan-Kettering Institute For Cancer Research Method for increasing the concentration of ascorbic acid in brain tissues of a subject
AU768543B2 (en) * 1998-06-22 2003-12-18 Nuo Therapeutics, Inc. Improved enriched platelet wound healant
US6524568B2 (en) 1998-06-22 2003-02-25 Cytomedix, Inc. Enriched platelet wound healant
DE19913427A1 (de) * 1999-03-25 2000-09-28 Wella Ag Verwendung von reduzierenden Verbindungen zur Verstärkung und Strukturverbesserung von Keratin enthaltenden Materialien
US8188043B2 (en) * 1999-07-28 2012-05-29 The Board Of Trustees Of The Leland Stanford Jr. University Nicotine in therapeutic angiogenesis and vasculogenesis
AU7776701A (en) 2000-08-10 2002-02-25 Santen Pharmaceutical Co Ltd Skin wound healing promoters
DE10128911A1 (de) * 2001-06-15 2002-12-19 Beiersdorf Ag Verwendung von Ascorbinsäure zur Herstellung angiogenetisch wirksamer topischer Zubereitungen
DE10128818A1 (de) * 2001-06-15 2002-12-19 Beiersdorf Ag Verwendung von Wirkstoffkombinationen aus Ascorbinsäure und einem oder mehreren Biochinonen zur Herstellung angiogenetisch wirksamer topischer Zubereitungen
FR2828401B1 (fr) * 2001-08-10 2003-11-07 Oreal Composition cosmetique ou dermatologique comprenant une association entre l'igf1 et/ou un compose mimetique de l'igf1, et l'acide ascorbique et/ou au moins l'un de ses derives
US20050142208A1 (en) 2002-05-09 2005-06-30 Won Min Yoo Pharmceutical composition for treatment of wounds conntaining blood plasma or serum
DE10355085A1 (de) * 2003-11-24 2005-06-23 Schure, Frank, Dr. Wundverband
CN115607506B (zh) * 2022-12-17 2023-04-28 朗肽生物制药股份有限公司 含重组人碱性成纤维细胞生长因子无水膏剂制备方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0326151A2 (en) * 1988-01-29 1989-08-02 Sumitomo Pharmaceuticals Company, Limited Improved controlled release formulation
EP0357240A2 (en) * 1988-08-03 1990-03-07 Ethicon, Inc. EGF for preventing tissue damage after ischemia

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987001728A1 (en) * 1985-09-12 1987-03-26 Biotechnology Research Partners, Ltd. Recombinant fibroblast growth factors
JP2879148B2 (ja) * 1987-07-07 1999-04-05 サイオス インコーポレイテッド 組換え繊維芽細胞成長因子
PH25859A (en) * 1988-01-11 1991-12-02 Takeda Chemical Industries Ltd Composition for treatment of ischemic disorder

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0326151A2 (en) * 1988-01-29 1989-08-02 Sumitomo Pharmaceuticals Company, Limited Improved controlled release formulation
EP0357240A2 (en) * 1988-08-03 1990-03-07 Ethicon, Inc. EGF for preventing tissue damage after ischemia

Also Published As

Publication number Publication date
DE69131318T2 (de) 1999-12-16
GR1002610B (el) 1997-02-20
EP0493985A1 (en) 1992-07-08
CA2058597C (en) 2002-07-23
GR910100515A (el) 1992-12-30
ATE181082T1 (de) 1999-06-15
EP0493985B1 (en) 1999-06-09
JPH0570365A (ja) 1993-03-23
CA2058597A1 (en) 1992-07-03
AU9008691A (en) 1992-07-09
ES2132082T3 (es) 1999-08-16
DE69131318D1 (de) 1999-07-15

Similar Documents

Publication Publication Date Title
NZ222551A (en) A method of healing wounds and a method of regenerating bone; pharmaceutical composition of platelet-derived growth factor and insulin-like growth factor
UA42747C2 (uk) Похідні пептиду,фармацевтична композиція та спосіб стимулювання секреції гормону росту
SG94684A1 (en) Wound healing compositions containing fibroblast growth factor and ascorbic acid
IL96841A0 (en) Compositions and method for the treatment of osteoporosis in mammals
EP0455422A3 (en) Method of treating or preventing baldness with compositions containing fibroblast growth factor
CA2106073A1 (en) Composition for promoting tissue repair and regeneration
EP0190018A3 (en) Use of transforming growth factor to promote wound healing and composition therefor
AU1473792A (en) Treatment of periodontitis
MY110734A (en) Improvements in or relating to dioic acids.
GB2264235B (en) Composition for nasal treatment
ZA941827B (en) Ointment for wound treatment
GR3032266T3 (en) Wound healing
ATE96329T1 (de) Topisch anwendbare pharmazeutische zubereitung.
EP0934748A3 (en) Von Willenbrand factor (vWF)- containing preparation, process for preparing vWF-containing preparations, and use of such preparations
IL100701A0 (en) Malic acid derivatives and compositions for the treatment of psoriasis
IL98156A0 (en) Pharmaceutical compositions containing magnesium-pyridoxal-5'-phosphate-glutaminate
CA2060208A1 (en) Wound healing
CA2110410A1 (en) Therapeutic Compositions for Osteoinduction
NZ236614A (en) Therapeutic composition containing corticosteroid and igf-i, the igf-i reducing or preventing the adverse effects of the corticosteroid
EP0550035A3 (en) Composition of stabilized fibroblast growth factor
IT1240683B (it) Composizione farmaceutica contenente egf
IL102274A0 (en) Adhesive compositions for dental treatment
GB9300644D0 (en) Composition for accelerating wound healing
IL99236A0 (en) Pharmaceutical composition for the topical treatment of psoriasis
IL101313A0 (en) Compositions and methods for increasing oxygen delivery to tissue